BindingDB logo
myBDB logout

null

SMILES: CN(C)C1CCN(C1)c1ccc(cc1F)N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O

InChI Key: InChIKey=OOJBFRLPFIZHEB-VGAJERRHSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 497409   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497409
PNG
(US11008301, Example 83)
Show SMILES CN(C)C1CCN(C1)c1ccc(cc1F)N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O |r|
Show InChI InChI=1S/C24H29ClFN5O2/c1-29(2)19-11-13-30(15-19)22-10-9-18(14-20(22)26)31-12-3-4-21(23(31)32)28-24(33)27-17-7-5-16(25)6-8-17/h5-10,14,19,21H,3-4,11-13,15H2,1-2H3,(H2,27,28,33)/t19?,21-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 1.10E+3n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497409
PNG
(US11008301, Example 83)
Show SMILES CN(C)C1CCN(C1)c1ccc(cc1F)N1CCC[C@@H](NC(=O)Nc2ccc(Cl)cc2)C1=O |r|
Show InChI InChI=1S/C24H29ClFN5O2/c1-29(2)19-11-13-30(15-19)22-10-9-18(14-20(22)26)31-12-3-4-21(23(31)32)28-24(33)27-17-7-5-16(25)6-8-17/h5-10,14,19,21H,3-4,11-13,15H2,1-2H3,(H2,27,28,33)/t19?,21-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.390n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair